Please Wait

Applying Filters...

Looking for Pharmaceutical Excipients offered by Actylis? Find Cis Atracurium Besylate to address your drug delivery challenges on PharmaCompass.

Cis Atracurium Besylate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

30 API Suppliers, 13 USDMF, 6 CEP/COS, 1 EU WC, 6 NDC API, 17 Listed Suppliers

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

114 FDF Dossiers, 46 FDA Orange Book, 24 Europe, 2 Canada, 11 South Africa, 31 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Actylis, 2 Finar

EXCIPIENTS BY APPLICATIONS

2 Parenteral, 2 Topical, 1 Solubilizers

DIGITAL CONTENT

28 News #PharmaBuzz

28 News #PharmaBuzz

MARKET PLACE

14 APIs, 10 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 6 USP, 1 Others

Xls

Filters

Cis Atracurium Besylate

Filters

FILTER :

filter Company Reset all filters

4 All

01 1Actylis

02 3Finar

filter Capability Reset all filters

filter Country Reset all filters

01

Actylis

BENZYL ALCOHOL MULTI-COMPENDIAL

PEGS Boston Summit

Not Confirmed

02

Finar

PEGS Boston Summit

Not Confirmed

03

Finar

BENZENESULFONIC ACID

PEGS Boston Summit

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.